189 related articles for article (PubMed ID: 35105948)
1. First use of gene therapy to treat growth hormone resistant dwarfism in a mouse model.
Sia KC; Gan SU; Mohd Rodhi SH; Fu ZY; Kopchick JJ; Waters MJ; Lee KO
Gene Ther; 2022 Jun; 29(6):346-356. PubMed ID: 35105948
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone receptor-deficient pigs resemble the pathophysiology of human Laron syndrome and reveal altered activation of signaling cascades in the liver.
Hinrichs A; Kessler B; Kurome M; Blutke A; Kemter E; Bernau M; Scholz AM; Rathkolb B; Renner S; Bultmann S; Leonhardt H; de Angelis MH; Nagashima H; Hoeflich A; Blum WF; Bidlingmaier M; Wanke R; Dahlhoff M; Wolf E
Mol Metab; 2018 May; 11():113-128. PubMed ID: 29678421
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic spectrum and responses to recombinant human IGF1 (rhIGF1) therapy in patients with homozygous intronic pseudoexon growth hormone receptor mutation.
Chatterjee S; Shapiro L; Rose SJ; Mushtaq T; Clayton PE; Ten SB; Bhangoo A; Kumbattae U; Dias R; Savage MO; Metherell LA; Storr HL
Eur J Endocrinol; 2018 May; 178(5):481-489. PubMed ID: 29500309
[TBL] [Abstract][Full Text] [Related]
4. Serum IGF-1 is insufficient to restore skeletal size in the total absence of the growth hormone receptor.
Wu Y; Sun H; Basta-Pljakic J; Cardoso L; Kennedy OD; Jasper H; Domené H; Karabatas L; Guida C; Schaffler MB; Rosen CJ; Yakar S
J Bone Miner Res; 2013 Jul; 28(7):1575-86. PubMed ID: 23456957
[TBL] [Abstract][Full Text] [Related]
5. Generation of a miniature pig disease model for human Laron syndrome.
Cui D; Li F; Li Q; Li J; Zhao Y; Hu X; Zhang R; Li N
Sci Rep; 2015 Oct; 5():15603. PubMed ID: 26511035
[TBL] [Abstract][Full Text] [Related]
6. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse).
Zhou Y; Xu BC; Maheshwari HG; He L; Reed M; Lozykowski M; Okada S; Cataldo L; Coschigamo K; Wagner TE; Baumann G; Kopchick JJ
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13215-20. PubMed ID: 9371826
[TBL] [Abstract][Full Text] [Related]
7. Growth Hormone Receptor Mutations Related to Individual Dwarfism.
Lin S; Li C; Li C; Zhang X
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29748515
[TBL] [Abstract][Full Text] [Related]
8. Reporting a novel growth hormone receptor gene variant in an Iranian consanguineous pedigree with Laron syndrome: a case report.
Bitarafan F; Khodaeian M; Garrousi F; Khalesi R; Ghazi Nader D; Karimi B; Alibakhshi R; Garshasbi M
BMC Endocr Disord; 2023 Jul; 23(1):155. PubMed ID: 37474955
[TBL] [Abstract][Full Text] [Related]
9. A half-century of studies of growth hormone insensitivity/Laron syndrome: A historical perspective.
Rosenbloom AL
Growth Horm IGF Res; 2016 Jun; 28():46-50. PubMed ID: 26276451
[TBL] [Abstract][Full Text] [Related]
10. Tissue-specific regulation of growth hormone (GH) receptor and insulin-like growth factor-I gene expression in the pituitary and liver of GH-deficient (lit/lit) mice and transgenic mice that overexpress bovine GH (bGH) or a bGH antagonist.
Iida K; Del Rincon JP; Kim DS; Itoh E; Nass R; Coschigano KT; Kopchick JJ; Thorner MO
Endocrinology; 2004 Apr; 145(4):1564-70. PubMed ID: 14726438
[TBL] [Abstract][Full Text] [Related]
11. Novel growth hormone receptor gene mutation in a patient with Laron syndrome.
Arman A; Yüksel B; Coker A; Sarioz O; Temiz F; Topaloglu AK
J Pediatr Endocrinol Metab; 2010 Apr; 23(4):407-14. PubMed ID: 20583548
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone insensitivity syndrome caused by a heterozygous GHR mutation: phenotypic variability owing to moderation by nonsense-mediated decay.
Gorbenko del Blanco D; de Graaff LC; Visser TJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2012 May; 76(5):706-12. PubMed ID: 22117696
[TBL] [Abstract][Full Text] [Related]
13. Functional changes of the liver in the absence of growth hormone (GH) action - Proteomic and metabolomic insights from a GH receptor deficient pig model.
Riedel EO; Hinrichs A; Kemter E; Dahlhoff M; Backman M; Rathkolb B; Prehn C; Adamski J; Renner S; Blutke A; de Angelis MH; Bidlingmaier M; Schopohl J; Arnold GJ; Fröhlich T; Wolf E
Mol Metab; 2020 Jun; 36():100978. PubMed ID: 32277923
[TBL] [Abstract][Full Text] [Related]
14. Transgenic Wuzhishan minipigs designed to express a dominant-negative porcine growth hormone receptor display small stature and a perturbed insulin/IGF-1 pathway.
Li F; Li Y; Liu H; Zhang X; Liu C; Tian K; Bolund L; Dou H; Yang W; Yang H; Staunstrup NH; Du Y
Transgenic Res; 2015 Dec; 24(6):1029-42. PubMed ID: 26510874
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Molecular Features of Laron Syndrome, A Genetic Disorder Protecting from Cancer.
Janecka A; Kołodziej-Rzepa M; Biesaga B
In Vivo; 2016; 30(4):375-81. PubMed ID: 27381597
[TBL] [Abstract][Full Text] [Related]
16. Mouse models of growth hormone insensitivity.
Young J; Bell S; Qian Y; Hyman C; Berryman DE
Rev Endocr Metab Disord; 2021 Mar; 22(1):17-29. PubMed ID: 33037595
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel mutation in the human growth hormone receptor gene (GHR) in a patient with Laron syndrome.
Gennero I; Edouard T; Rashad M; Bieth E; Conte-Aurio F; Marin F; Tauber M; Salles JP; El Kholy M
J Pediatr Endocrinol Metab; 2007 Jul; 20(7):825-31. PubMed ID: 17849745
[TBL] [Abstract][Full Text] [Related]
18. Fifty seven years of follow-up of the Israeli cohort of Laron Syndrome patients-From discovery to treatment.
Laron Z; Kauli R
Growth Horm IGF Res; 2016 Jun; 28():53-6. PubMed ID: 26307357
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation by growth hormone (GH) of insulin-like growth factor I and GH receptor/binding protein gene expression in rat liver.
Maiter D; Walker JL; Adam E; Moatsstaats B; Mulumba N; Ketelslegers JM; Underwood LE
Endocrinology; 1992 Jun; 130(6):3257-64. PubMed ID: 1375898
[TBL] [Abstract][Full Text] [Related]
20. High growth hormone serum partially protects mice against Trypanosoma cruzi infection.
Mora-Criollo P; Basu R; Qian Y; Funk K; Bell S; Young JA; List EO; Costales JA; Guevara-Aguirre J; Grijalva MJ; Kopchick JJ
FEBS Open Bio; 2023 Jul; 13(7):1346-1356. PubMed ID: 37163287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
